Advertisement

High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation

Koichi Miyamura, Takuya Yamashita, Yoshiko Atsuta, Tatsuo Ichinohe, Koji Kato, Naoyuki Uchida, Takahiro Fukuda, Kazuteru Ohashi, Hiroyasu Ogawa, Tetsuya Eto, Masami Inoue, Satoshi Takahashi, Takehiko Mori, Heiwa Kanamori, Hiromasa Yabe, Asahito Hama, Shinichiro Okamoto and Yoshihiro Inamoto

Article Information

Citation 
vol. 3 no. 3 397-405
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted September 13, 2018
  • Accepted January 9, 2019
  • Published online February 6, 2019.


Contributors 
  • Koichi Miyamura, 1Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan;
  • Takuya Yamashita, 2Department of Hematology, St. Luke’s International Hospital, Tokyo, Japan;
  • Yoshiko Atsuta, 3Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan;4Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan;
  • Tatsuo Ichinohe, 5Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan;
  • Koji Kato, 6Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan;
  • Naoyuki Uchida, 7Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan;
  • Takahiro Fukuda, 8Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan;
  • Kazuteru Ohashi, 9Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;
  • Hiroyasu Ogawa, 10Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine; Nishinomiya, Japan;
  • Tetsuya Eto, 11Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan;
  • Masami Inoue, 12Department of Hematology/Oncology, Osaka Women’s and Children’s Hospital, Izumi, Japan;
  • Satoshi Takahashi, 13Division of Molecular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan;
  • Takehiko Mori, 14Division of Hematology, Keio University School of Medicine, Tokyo, Japan;
  • Heiwa Kanamori, 15Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan; and
  • Hiromasa Yabe, 16Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine, Kanagawa, Japan
  • Asahito Hama, 6Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan;
  • Shinichiro Okamoto, 14Division of Hematology, Keio University School of Medicine, Tokyo, Japan;
  • Yoshihiro Inamoto, 8Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output